{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T02:49:16Z","timestamp":1785120556745,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.biopha.2024.117778","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T05:48:01Z","timestamp":1735105681000},"page":"117778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Dipeptidyl peptidase-4 inhibitor linagliptin reduces inflammatory response, ameliorates tissue edema formation, and improves survival in severe sepsis"],"prefix":"10.1016","volume":"182","author":[{"given":"Denis","family":"Delic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian T.","family":"Wohnhaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2620-6156","authenticated-orcid":false,"given":"Jin-Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117778_bib1","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"10","key":"10.1016\/j.biopha.2024.117778_bib2","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1182\/blood-2002-06-1887","article-title":"The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome","volume":"101","author":"Aird","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.biopha.2024.117778_bib3","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s12325-017-0622-8","article-title":"Sepsis: a review of advances in management","volume":"34","author":"Rello","year":"2017","journal-title":"Adv. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2024.117778_bib4","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1097\/CCM.0b013e31825fdc31","article-title":"Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis","volume":"40","author":"David","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.biopha.2024.117778_bib5","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ni1525","article-title":"Role reversal' for the receptor PAR1 in sepsis-induced vascular damage","volume":"8","author":"Kaneider","year":"2007","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117778_bib6","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1097\/PCC.0000000000002266","article-title":"The endothelial glycocalyx: a fundamental determinant of vascular permeability in sepsis","volume":"21","author":"Fern\u00e1ndez-Sarmiento","year":"2020","journal-title":"Pediatr. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.117778_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12967-020-02342-8","article-title":"Kinin B1 receptor: a potential therapeutic target in sepsis-induced vascular hyperpermeability","volume":"18","author":"Ruiz","year":"2020","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.biopha.2024.117778_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00395-015-0465-x","article-title":"Gliptin and GLP-1 analog treatment improves survival and vascular inflammation\/dysfunction in animals with lipopolysaccharide-induced endotoxemia","volume":"110","author":"Steven","year":"2015","journal-title":"Basic Res. Cardiol."},{"issue":"16","key":"10.1016\/j.biopha.2024.117778_bib9","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.3390\/ijms20164052","article-title":"Neuroprotective properties of linagliptin: focus on biochemical mechanisms in cerebral ischemia, vascular dysfunction and certain neurodegenerative diseases","volume":"20","author":"Wici\u0144ski","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.117778_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14728222.2021.1897107","article-title":"Emerging therapeutic targets for sepsis","volume":"25","author":"Tindal","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"issue":"8","key":"10.1016\/j.biopha.2024.117778_bib11","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3390\/jcm12082892","article-title":"Treatment advances in sepsis and septic shock: modulating pro- and anti-inflammatory mechanisms","volume":"12","author":"Marques","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.117778_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cvr\/cvs246","article-title":"Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition","volume":"96","author":"Kr\u00f6ller-Sch\u00f6n","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.biopha.2024.117778_bib13","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.3390\/ijms23063065","article-title":"The dipeptidyl peptidase-4 inhibitor linagliptin ameliorates endothelial inflammation and microvascular thrombosis in a sepsis mouse model","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.biopha.2024.117778_bib14","doi-asserted-by":"crossref","first-page":"11190","DOI":"10.3390\/ijms222011190","article-title":"Linagliptin protects against endotoxin-induced acute kidney injury in rats by decreasing inflammatory cytokines and reactive oxygen species","volume":"22","author":"Wu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117778_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119295","article-title":"Linagliptin mitigates experimental inflammatory bowel disease in rats by targeting inflammatory and redox signaling","volume":"273","author":"Arab","year":"2021","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.biopha.2024.117778_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143941","article-title":"The dipeptidyl peptidase-4 inhibitor linagliptin preserves endothelial function in mesenteric arteries from type 1 diabetic rats without decreasing plasma glucose","volume":"10","author":"Salheen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.117778_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.lfs.2016.02.067","article-title":"Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes","volume":"159","author":"Hardigan","year":"2016","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.117778_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231196","article-title":"e-PREDICE consortium, early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data","volume":"15","author":"Gabriel","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biopha.2024.117778_bib19","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.3389\/fimmu.2018.02996","article-title":"Linagliptin attenuates the cardiac dysfunction associated with experimental sepsis in mice with pre-existing type 2 diabetes by inhibiting NF-kappaB","volume":"18","author":"Al Zoubi","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117778_bib20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12967-021-03016-9","article-title":"Inhibition of microsomal prostaglandin E synthase-1 ameliorates acute lung injury in mice","volume":"19","author":"Gurusamy","year":"2021","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.117778_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40635-016-0096-z","article-title":"Sepsis modeling in mice: ligation length is a major severity factor in cecal ligation and puncture","volume":"4","author":"Ruiz","year":"2016","journal-title":"Intensive Care Med. Exp."},{"issue":"3-4","key":"10.1016\/j.biopha.2024.117778_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/hum.2021.083","article-title":"Dexamethasone transiently enhances transgene expression in the liver when administered at late-phase post long-term adeno-associated virus transduction","volume":"33","author":"Chai","year":"2022","journal-title":"Hum. Gene Ther."},{"issue":"7","key":"10.1016\/j.biopha.2024.117778_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/11630900-000000000-00000","article-title":"Clinical pharmacokinetics and pharmacodynamics of linagliptin","volume":"51","author":"Graefe-Mody","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.biopha.2024.117778_bib24","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1097\/CCM.0000000000001268","article-title":"Kinin B1 receptor antagonist BI113823 reduces acute lung injury","volume":"43","author":"Nasseri","year":"2015","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.117778_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40001-023-01037-2","article-title":"Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice","volume":"28","author":"Gurusamy","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.biopha.2024.117778_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2024.117778_bib27","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"432","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.biopha.2024.117778_bib28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1345\/aph.1Q522","article-title":"Pharmacology, efficacy, and safety of linagliptin for the treatment of type 2 diabetes mellitus","volume":"46","author":"Neumiller","year":"2012","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2024.117778_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1517\/14740338.2014.971008","article-title":"Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation","volume":"14","author":"Barnett","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"issue":"8","key":"10.1016\/j.biopha.2024.117778_bib30","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.3390\/biomedicines10082026","article-title":"Role of dipeptidyl peptidase-4 (DPP4) on COVID-19 physiopathology","volume":"10","author":"Sebasti\u00e1n-Mart\u00edn","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.biopha.2024.117778_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/cei.12757","article-title":"Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and\/or structure homologue (DASH) proteins","volume":"184","author":"Wagner","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117778_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12781","article-title":"Cut to the chase: a review of CD26\/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system","volume":"185","author":"Klemann","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117778_bib33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jphs.2018.12.004","article-title":"A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4","volume":"139","author":"Yamaguchi","year":"2019","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2024.117778_bib34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00011-018-1129-8","article-title":"Vascular endothelium dysfunction: a conservative target in metabolic disorders","volume":"67","author":"Jamwal","year":"2018","journal-title":"Inflamm. Res."},{"issue":"3","key":"10.1016\/j.biopha.2024.117778_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/iub.1610","article-title":"The endothelial border to health: mechanistic evidence of the hyperglycemic culprit of inflammatory disease acceleration","volume":"69","author":"Hansen","year":"2017","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.biopha.2024.117778_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12933-018-0704-1","article-title":"The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin","volume":"17","author":"Aroor","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2024.117778_bib37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/jdi.12587","article-title":"Linagliptin improves endothelial function in patients with type 2 diabetes: a randomized study of linagliptin effectiveness on endothelial function","volume":"8","author":"Shigiyama","year":"2017","journal-title":"J. Diabetes Investig."},{"issue":"7","key":"10.1016\/j.biopha.2024.117778_bib38","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1210\/en.2013-1096","article-title":"Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin resistant male Zucker obese rats","volume":"154","author":"Aroor","year":"2013","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.biopha.2024.117778_bib39","article-title":"Role of glucagon-like peptide-1 (GLP-1) receptor agonists in cardiovascular risk management in patients with type 2 diabetes mellitus: a systematic review","volume":"15","author":"Parab","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.biopha.2024.117778_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/157339910791658853","article-title":"Impact of GLP-1 and GLP-1 receptor agonists on cardiovascular risk factors in type 2 diabetes","volume":"6","author":"Verge","year":"2010","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.biopha.2024.117778_bib41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.vph.2015.08.011","article-title":"Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice","volume":"79","author":"Salim","year":"2016","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.biopha.2024.117778_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/er.2011-1052","article-title":"Cardiovascular biology of the incretin system","volume":"33","author":"Ussher","year":"2012","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.117778_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2010.12.131","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury","volume":"405","author":"Goto","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2024.117778_bib44","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.3390\/cancers13235947","article-title":"The serine protease CD26\/DPP4 in non-transformed and malignant T cells","volume":"13","author":"Chitadze","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.117778_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-3083.2001.00984.x","article-title":"CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes","volume":"54","author":"Gorrell","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.biopha.2024.117778_bib46","article-title":"Emerging role of dipeptidyl peptidase-4 in autoimmune disease","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117778_bib47","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1073\/pnas.0501050102","article-title":"CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse","volume":"102","author":"Pacheco","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224016652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224016652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:10:36Z","timestamp":1776726636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224016652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":47,"alternative-id":["S0753332224016652"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117778","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dipeptidyl peptidase-4 inhibitor linagliptin reduces inflammatory response, ameliorates tissue edema formation, and improves survival in severe sepsis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117778"}}